NYSE:UPH - New York Stock Exchange, Inc. - US91532B2007 - Common Stock - Currency: USD
NYSE:UPH (12/11/2023, 8:20:46 PM)
0.3
+0.03 (+9.13%)
The current stock price of UPH is 0.3 USD. In the past month the price decreased by -74.79%. In the past year, price decreased by -94%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
VEEV | VEEVA SYSTEMS INC-CLASS A | 36.13 | 36.66B | ||
DOCS | DOXIMITY INC-CLASS A | 56.54 | 13.58B | ||
WAY | WAYSTAR HOLDING CORP | N/A | 7.26B | ||
CERT | CERTARA INC | 33.77 | 2.12B | ||
TDOC | TELADOC HEALTH INC | N/A | 1.98B | ||
GDRX | GOODRX HOLDINGS INC-CLASS A | 15.03 | 1.83B | ||
SDGR | SCHRODINGER INC | N/A | 1.65B | ||
PHR | PHREESIA INC | N/A | 1.64B | ||
EVH | EVOLENT HEALTH INC - A | 15.8 | 1.22B | ||
HSTM | HEALTHSTREAM INC | 50.58 | 999.88M | ||
LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 966.46M | ||
DH | DEFINITIVE HEALTHCARE CORP | 14.47 | 762.50M |
UpHealth, Inc. operates as a digital health company. The company is headquartered in Delray Beach, Florida and currently employs 45 full-time employees. The company went IPO on 2019-06-10. The firm operates through three segments: Integrated Care Management, Virtual Care Infrastructure, and Services. The Integrated Care Management segment provides guidance and tools to enhance population health through its SyntraNet platform. This platform improves overall health system performance by leveraging capabilities in data and analytics, health information exchanges, pharmacy care services, health care operations, and population health. The Virtual Care Management leverages digital health tools, technology, data, and analytics to provide telehealth solutions, which use electronic information and telecommunications technologies to support and promote long-distance clinical health care, patient and professional health-related education, and virtual care infrastructure solutions. The Services platform provides behavioral health, mental health, and pharmacy services in the United States.
UPHEALTH INC
14000 S. Military Trail, Suite 203
Delray Beach FLORIDA US
CEO: Raluca Dinu
Employees: 45
Company Website: https://uphealthinc.com/
Phone: 18884243646
The current stock price of UPH is 0.3 USD. The price increased by 9.13% in the last trading session.
The exchange symbol of UPHEALTH INC is UPH and it is listed on the New York Stock Exchange, Inc. exchange.
UPH stock is listed on the New York Stock Exchange, Inc. exchange.
8 analysts have analysed UPH and the average price target is 5.24 USD. This implies a price increase of 1646.75% is expected in the next year compared to the current price of 0.3. Check the UPHEALTH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
UPHEALTH INC (UPH) has a market capitalization of 5.33M USD. This makes UPH a Nano Cap stock.
UPHEALTH INC (UPH) currently has 45 employees.
The Revenue of UPHEALTH INC (UPH) is expected to decline by -7.87% in the next year. Check the estimates tab for more information on the UPH EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
UPH does not pay a dividend.
UPHEALTH INC (UPH) will report earnings on 2024-02-29, after the market close.
UPHEALTH INC (UPH) does not have a PE ratio as the earnings reported over the last twelve months were negative (-7.7).
ChartMill assigns a fundamental rating of 1 / 10 to UPH. UPH may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months UPH reported a non-GAAP Earnings per Share(EPS) of -7.7. The EPS increased by 34.97% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -31.98% | ||
ROE | -117.29% | ||
Debt/Equity | 0.03 |
ChartMill assigns a Buy % Consensus number of 83% to UPH. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of 72.87% and a revenue growth -7.87% for UPH